Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : dsco Discovery Laboratories -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (51)	11/25/2003 3:11:32 PM
From: Cacaito	Respond to of 318

It also seems that all the good future already in price, almost like a xoma all over again. They have to prove that they can take the market from the others, those numbers against Exosurf were expected, the 14 day (and not the 28 day)mortality is interesting that the Fda allowed it, fine. But, the numbers against Survanta are quite striking (they did not provided but they are certainly statistically significant), it could be argue that thanks to it they could price the product better. Very nice, I will take a position soon.